⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SBFM News
Sunshine Biopharma Inc.
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
accessnewswire.com
SBFM
Form 8-K
sec.gov
SBFM
SBFMW
Form 8-K
sec.gov
SBFMW
SBFM
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
accessnewswire.com
SBFM
SBFM
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
accessnewswire.com
SBFM
Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin
accessnewswire.com
SBFM
Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)
accessnewswire.com
SBFM
SBFM
Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)
accessnewswire.com
SBFM
SBFM
Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience
accessnewswire.com
SBFM
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections
accessnewswire.com
SBFM